3Chevalier T, Brisgand P, Douilard JY, et al. Randomized study of vinoredine and cisplatin versus vindesine and cis platin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial inclu ding 612 patients[J]. J ClinOncol,1994,12(2): 360.
4Mencoboni M, Lerza R, Castello G,et al. Feasibility and toxicity of combination chemotherapy with ifosfamid, vinorelbine,cisplatin versus ifosfamide, vinorelbine in paa tients with advanced non small cell lung cancer[J]. Anti Cancer Res,1997,17(4A) :2795.
5Chevalier T, Brisgand P, Douilard JY, et al. Randomized study of vinoredine and cisplatin versus vindesine and cis platin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial inclu ding 612 patients[J]. J Clin Oncol 1994,12(2): 360.
6Paul A, Bunn PAJr, Kelly K. New chemotherapeutic a gents prolong survival and improve quality of life in non small cell lung cancer: a review of the literature and fu ture directions[J]. Clin Cancer Res,1998,4(5): 1087.
7Landonio G, Sartore Bianchi A, Giannetta L. Controversies in the management of brain metastases: the role of chemotherapy[J]. Forum (Genova), 2001,11(1): 59.
8Pujol JL von-Pawel J, Tumolo S, et al. Preliminary re sults of combined therapy with topotecan and carboplatin in advanced non-small-cell lung cancer[J]. Oncology, 2001,61 Suppl 1: 47.
9Stupp R, Bodmer A Duvoisin B, et al. Is cisplatin re quired for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase Ⅰ / Ⅱ trial with topotecan and vinorelbine[J]. Oncology. 2001, 61 Suppl 1: 35.
10Eckardt JR. Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancer[J]. On cology, 2001,61 Suppl 1: 30.
